|
|
|
Insider
Information: |
David Eric |
Relationship: |
CSO & EVP Pre-Clinical... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
876,609 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$911,673 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
876,609 |
|
|
Total
Value |
$911,673 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Organovo Holdings, Inc. |
ONVO |
CSO & EVP Pre-Clinical... |
2017-11-16 |
876,609 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONVO |
Organovo Holdings, Inc. |
Chief Strategy Officer |
|
2013-10-07 |
4 |
AS |
$5.86 |
$368,953 |
D/D |
(63,000) |
731,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
Chief Strategy Officer |
|
2013-10-10 |
4 |
OE |
$1.00 |
$20,000 |
D/D |
20,000 |
751,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
Chief Strategy Officer |
|
2013-10-10 |
4 |
S |
$5.66 |
$19,996 |
D/D |
(3,530) |
747,776 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
Chief Strategy Officer |
|
2013-11-13 |
4 |
S |
$10.39 |
$171,105 |
D/D |
(16,470) |
731,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
Chief Strategy Officer |
|
2014-09-12 |
4 |
AS |
$7.30 |
$218,973 |
D/D |
(30,000) |
701,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
Chief Strategy Officer |
|
2014-12-29 |
4 |
AS |
$7.50 |
$27,754 |
D/D |
(3,700) |
697,706 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
Chief Strategy Officer |
|
2014-12-30 |
4 |
AS |
$7.56 |
$123,243 |
D/D |
(16,300) |
681,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
Chief Strategy OfficerOfficer |
|
2012-05-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
794,306 |
|
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2016-03-30 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
676,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2016-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
726,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2016-08-05 |
4 |
AS |
$4.55 |
$91,000 |
D/D |
(20,000) |
706,306 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2016-08-19 |
4 |
D |
$4.00 |
$4,822 |
D/D |
(1,205) |
705,101 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2016-11-16 |
4 |
D |
$3.26 |
$5,688 |
D/D |
(1,745) |
703,356 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2017-02-16 |
4 |
D |
$2.95 |
$4,101 |
D/D |
(1,390) |
701,966 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2017-05-16 |
4 |
D |
$2.86 |
$3,615 |
D/D |
(1,263) |
700,703 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2017-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
190,000 |
890,703 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2017-08-16 |
4 |
D |
$2.06 |
$17,446 |
D/D |
(8,469) |
882,234 |
0 |
- |
|
ONVO |
Organovo Holdings, Inc. |
CSO & EVP Pre-Clinical Dev |
|
2017-11-16 |
4 |
D |
$1.47 |
$8,270 |
D/D |
(5,625) |
876,609 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|